One of Prince William's Most "Important" Hobbies Is a Little Unexpected but Directly Related to His Three Children—George, Charlotte, and Louis Tropical Storm Imelda has formed, and there’s been a big ...

His time is up and the last time might have come and gone, very soon, you won't be seeing John Cena in a WWE ring anymore. At the time of writing, the "Leader of the Cenation" has entered the final ...

WWE Hall of Famer Jerry 'The King' Lawler was forced to pull out of a public appearance this week after suffering his third stroke in the space of seven years. According to TMZ Sports, Lawler, 75, is ...

Ronda Rousey believes WWE pitted her against Alexa Bliss for one particular reason. During a recent appearance on The Lapsed Fan podcast, the former “Baddest Woman on the Planet” spoke about her WWE ...

Professional wrestling star Jonathan Echevarria, best known by his ring name Jaka, died on Sunday at age 39 after suffering a heart attack in the days following his final in-ring appearance.

Sony has revealed its PlayStation Plus lineup for September, and it’s one of those months where there’s no single theme. Instead, you get a mix of blockbuster wrestling, tactical spin-offs, gritty ...

Depraved sex offender Jason Mizner, 49, is serving 19 years for 65 child-sex offences involving a two-year-old girl in the early 2000s who he repeatedly raped over a three-month period. The sick ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

But what exactly is job hugging? And what does it suggest about today’s jobs market? Job hugging is a trend where employees are holding tightly to their current roles for longer than they might have ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small cell ...